|
|
Health officials are beginning to roll out a fourth COVID-19 vaccine jab for the elderly and those considered to be immunocompromised, but a debate is raging about whether another dose should be given to those who are otherwise healthy.
The Financial Times reported that the European Union’s drug regulator has raised concerns about the fourth jab for the general public, stating that another shot could “hypothetically overload people’s immune systems.”
“This hasn’t been demonstrated yet for COVID-19, but it’s something to study,” Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, told the paper.
The Trends Journal has reported on the new push for the fourth jab—mainly by Big Pharma and their servants in elected office. (See “FOURTH COVID-19 A ZERO SHOT?” “PFIZER CEO SELLING ‘GET YOUR FOURTH SHOT” and “MODERNA EXPECTS TO REAP $18.4 BILLION FROM VACCINE SALES.”)
We have pointed out that there have been some recent setbacks when it comes to the effectiveness of the fourth jab.
A recent Israeli study found that the fourth COVID-19 vaccine offers little to no protection from the virus when measured against young and otherwise healthy people who have been vaccinated and boosted.
TRENDPOST: As for the efficacy of the Operation Warp Speed inoculation? When it was hawked to the public back in 2020, it was sold that two shots would have 95 percent efficacy rate.
However, according to the Israeli health ministry back in July 2021, that number has shrunk to 39 percent. And now two shots won’t do the job… it’s doubled up to four. Yet, there is not a mention of this in the mainstream media.
The study was conducted by researchers at Israel’s Infection Prevention and Control Unit at Sheba Medical Center. Prof. Gili Regev-Yochay, head researcher of the study, said there were 600 participants, including 270 who took the fourth jab of either the Pfizer or Moderna vaccine, The New England Journal of Medicine said.
Regev-Yochay said researchers found no differences, “both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered.”
New Doubts
Dr. Anna Durbin, a public health expert at Johns Hopkins University, told ABC News that she does not believe that many Americans would stand to benefit from another booster.
“There are very few, if any, people who, in my opinion require a fourth dose,” she told The Daily Mail.
Dr. Paul Offit, who directs the Vaccine Education Center at Children’s Hospital of Philadelphia, asked, “Where’s the evidence?”
The U.S. Centers for Disease Control and Prevention has advised those who are immunocompromised to take the extra shot, but the paper pointed out that it has not been authorized by the Food and Drug Administration.
But the FDA is expected to approve the jab as soon as Tuesday, USA Today reported. The agency is reportedly trying to “hedge against a surge of infections—either from the BA.2 variant or another to come.”
England announced that it will be offering its fourth vaccine shot this week. The shot will be available for home care residents, those over 75 and the immunosuppressed.
“Our phenomenal vaccination program has saved countless lives and built a wall of defense which has allowed us to learn to live with Covid,” Sajid Javid, the U.K.’s Health and Social Care secretary, said. “Following the massive success of the rollout so far, we are now offering over-75s and the most vulnerable a spring booster dose to top up their protection against this virus.”